News | June 29, 2022
Glenmark Pharmaceuticals expand its OTC portfolio
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
The research here will mainly concentrate on the manufacturing process of biopharmaceuticals, especially in the area of advanced medicines, as well as the fermentation-based manufacture of ingredients for foods and food supplements
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
Strengthens investment in channels of the future to expand patient reach
The Congress was held on June, 20-21, 2022 in Berlin, Germany
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
Subscribe To Our Newsletter & Stay Updated
